#United States #New York #Rosen Law Firm #Securities Class Action #Immutep Ltd

The Rosen Law Firm Investigates Immutep Ltd. Securities Claims

Overview of the Investigation

Rosen Law Firm, renowned for advocating investor rights globally, is currently conducting a thorough investigation into potential securities claims on behalf of those who invested in Immutep Ltd. (NASDAQ: IMMP). This investigation stems from recent allegations that Immutep may have disseminated materially misleading business information to the public, leading to significant investor losses.

Details on the Allegations

On March 13, 2026, Immutep issued a concerning press release. It described a recommendation from the Independent Data Monitoring Committee (IDMC) regarding the TACTI-004 Phase III study evaluating their drug, eftilagimod alfa ('efti'), aimed at treating patients with non-small cell lung cancer. The IDMC suggested halting the trial following an interim futility analysis. The release stated that enrollment in the study would cease and the company would implement a structured wind-down of the trial, including essential patient follow-ups and site closure procedures in line with regulatory and ethical standards.

The immediate fallout from this announcement was devastating for Immutep’s stock data. The American Depositary Receipt (ADR) price plummeted by $2.28, marking a striking 82.6% drop to settle at $0.48 per ADR on the same day the press release was published. This dramatic decline raised concerns among investors and prompted the Rosen Law Firm to step in.

Join the Class Action

For those who purchased Immutep securities, there may be an opportunity for financial recovery without any out-of-pocket costs through the Rosen Law Firm’s contingency fee structure. The firm is preparing to initiate a class action lawsuit aimed at recouping the financial losses experienced by investors. If you are affected, it's crucial to act promptly. Interested investors can join the prospective class action by visiting the firm’s website at rosenlegal.com or contacting Phillip Kim, Esq. at 866-767-3653 or via email at [email protected].

Why Choose Rosen Law Firm?

Selecting competent legal representation is vital, especially in complex securities class action lawsuits. The Rosen Law Firm has established a solid reputation for successfully managing such cases, making it an appealing option for investors seeking justice and compensation. Notably, the firm has previously secured the largest settlement in a securities class action involving a Chinese company and has consistently ranked among the top law firms for class action settlements over the years. In 2019 alone, the firm recovered over $438 million for investors. Their founding partner, Laurence Rosen, is recognized as a leading figure in the Plaintiffs' Bar, further highlighting the firm’s expertise in handling these intricate legal matters.

Investors are encouraged to stay informed and updated via the firm's social media platforms, including LinkedIn, Twitter, and Facebook, where additional information and updates will be regularly shared.

Attorney advertising is a crucial aspect of this legal process, making prior results an important indicator of potential future outcomes. However, past successes do not guarantee similar results in every case.

Contact Information

For further inquiries and detailed assistance, investors can reach:

• - Laurence Rosen, Esq.
• - Phillip Kim, Esq.
• - The Rosen Law Firm, P.A.
• - 275 Madison Avenue, 40th Floor, New York, NY 10016
• - Phone: (212) 686-1060
• - Toll-Free: (866) 767-3653
• - Email: email protected]
• - Website: [www.rosenlegal.com

This investigation underscores the importance of vigilance in the ever-evolving landscape of securities investments. Investors should remain proactive and informed regarding their rights and possible remediation options available to them.